Functional MRI studies involving the precuneus, a region in the posterior of the brain, reveal what may be a new way to distinguish patients with mild cognitive impairment (MCI) from those with Alzheimer’s disease.
Functional MRI studies involving the precuneus, a region in the posterior of the brain, reveal what may be a new way to distinguish patients with mild cognitive impairment (MCI) from those with Alzheimer’s disease.
Previous research has associated specific atrophy of the precuneus, which appears to be involved in visuospatial functioning and retrieval of previously learned information, with Alzheimer’s. But for anatomical reasons this volume cannot be measured directly and must be assessed manually. Researchers at University Hospital Grenoble in France have evidence from T1, T2, and diffusion weighted MRI that a gradient of signal between the precuneus and the frontotemporal lobe also correlates with Alzheimer’s and MCI.
The French researchers based their study on a visual score of signal gradient, which they call K2, correlated by relating it to signals of antero-posterior enlargement of the cingular sulcus. They tested 105 patients with early or prodromal Alzheimer’s on the K2 scale, and found at least two patterns relating to the precuneus atrophy. When signal is more prominent in the frontal area, clearly the patient has frontotemporal dementia; absence of microangiopathy and stronger signal in the posterior, they suggest, indicates Alzheimer’s. Although more work is needed to quantify the clinical parameters, radiologist Alexandre Krainik said, the new scale should allow “better characterization of morphological subgroups” relevant to early dementia.
In related work at the University of Genoble, researchers evaluated cerebral vasoreactivity in dementia patients using BOLD fMRI after CO2 challenge, following up on studies in a transgenic mouse model of Alzheimer’s that found abnormalities in basal perfusion and vasoreactivity in the brain. Comparing BOLD and perfusion imaging, they found that the signal is delayed and the amperage lower in regions of interest for patients with Alzheimer’s and MCI. Cerebral vasoreactivitiy impairments were “diffuse,” they found, but seemed to predominate in posterior areas of the brain.
A technical problem may hinder interpretation of these results, commented Roland Wiest with the Institute of Diagnostic and Interventional Radiology of Bern, Switzerland. BOLD sequences are susceptible to air and signal deterioration coming from bone at the area of the mesotemporal lobe, he pointed out. Also he was concerned about the fact that the signal in relevant areas of the brain was diffuse. “One would have expected more specific patterns in MCI patients,” he said, “not diffusion.”
Still, the issue of volume loss in the precuneus, where the brain keeps vigilance, is very important, he said. “A lot of work remains to be done still,” he added, “but they’re going in a reasonable direction.”
ECR Study Finds Mixed Results with AI on Breast Ultrasound
March 6th 2024While adjunctive use of AI led to significantly higher specificity and accuracy rates in detecting cancer on breast ultrasound exams in comparison to unassisted reading by breast radiologists, researchers noted that 12 of 13 BI-RADS 3 lesions upgraded by AI were ultimately benign, according to research presented at the European Congress of Radiology.
Can Autonomous AI Help Reduce Prostate MRI Workloads Without Affecting Quality?
March 1st 2024Based on findings from a multicenter study of over 1,600 patients, researchers at the European Congress of Radiology suggest the inclusion of autonomous artificial intelligence (AI) triage could facilitate up to a 75 percent reduction in prostate MRI reading workload.
Five Insights on Artifacts and Limitations with Contrast-Enhanced Mammography
February 29th 2024Noting that technique issues, patient positioning miscues and atypical features can all contribute to faulty interpretation with contrast-enhanced mammography (CEM), researchers at the European Congress of Radiology shared their insights on navigating artifacts and limitations with CEM.
ECR Study Examines Key Predictive Factors for Metastasis in Patients with High-Risk Prostate Cancer
February 28th 2024Sixty-five percent of patients with newly diagnosed high-risk prostate cancer may have extraprostatic extension on MRI, and PSMA PET/CT findings suggest those with Gleason scores of eight or higher have more than double the risk of metastasis, according to a new study presented at the European Congress of Radiology (ECR).